ArticleLancet (London, England)2017
Essential medicines for universal health coverage - Authors' reply.
Article in Lancet (London, England), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Access to essential medicines used in the management of noncommunicable diseases in Southern Ethiopia: Analysis using WHO/HAI methodology.SAGE open medicine · 2024Article
- In-country availability of medical abortion medicines: a description of the framework and methodology of the WHO landscape assessments.Reproductive health · 2023Article
- Challenges to the Availability and Affordability of Essential Medicines in African Countries: A Scoping Review.ClinicoEconomics and outcomes research : CEOR · 2023Article
- Impact of the European Union on access to medicines in low- and middle-income countries: A scoping review.The Lancet regional health. Europe · 2021Article
- Cancer burden, finance, and health-care systems.The Lancet. Oncology · 2021Article
- Universal access to essential medicines as part of the right to health: a cross-national comparison of national laws, medicines policies, and health system indicators.Global health action · 2020Article
- Estimated effects of adding universal public coverage of an essential medicines list to existing public drug plans in Canada.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2017Article
- Health systems research on access to medicines: unpacking challenges in implementing policies in the face of the epidemiological transition.BMJ global health · 2017Article
Corrections and comments
- Comment on
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
28513447What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.